Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Apple TV adds Google Cast streaming, but only on Android

December 15, 2025

Global IIoT Adoption: Regional Analysis Reveals Unique Market Priorities and Growth Enablers Across Americas, EMEA, and APAC

December 15, 2025

United States Navy Issues Letter of Support

December 15, 2025

‘I’m getting lots of inquiries’ from MPs looking to join Liberals: minister

December 15, 2025

Digital Therapeutics Offer Hope to Rural Residents

December 15, 2025
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » New Study Finds Trimsulin Achieves 243% Greater Weight Loss than Semaglutide without Serious Side Effects
Press Release

New Study Finds Trimsulin Achieves 243% Greater Weight Loss than Semaglutide without Serious Side Effects

By News RoomOctober 24, 20242 Mins Read
New Study Finds Trimsulin Achieves 243% Greater Weight Loss than Semaglutide without Serious Side Effects
Share
Facebook Twitter LinkedIn Pinterest Email
New Study Finds Trimsulin Achieves 243% Greater Weight Loss than Semaglutide without Serious Side Effects

FRISCO, Texas, Oct. 24, 2024 (GLOBE NEWSWIRE) — A new preprint study found the Trimsulin Weight Loss Program, a nutraceutical plant-based supplement, outperformed leading weight loss drugs, semaglutide, and tirzepatide. Overweight adults using Trimsulin experienced significantly more weight loss with fewer side effects.

The study monitored 503 FFN participants over six months, comparing orally ingested Trimsulin against injectable semaglutide and tirzepatide. The results were impressive: Trimsulin users lost 14.1% of their body weight, compared to 5.8% for semaglutide and 10.1% for tirzepatide. Trimsulin provided superior weight loss and minimal adverse effects, with only 4.8% of participants reporting mild side effects.

No serious side effects were reported by Trimsulin users, whereas 3% of semaglutide and 5-7% of tirzepatide patients reported issues such as pancreatitis, bowel obstructions, psychiatric problems, and cardiovascular disorders.

Dr. Richard Clark Kaufman, lead researcher, remarked, “Trimsulin is a game-changer. Its nutraceutical composition stimulates the body to naturally release GLP-1 and GIP hormones and inhibits the enzyme DPP-4 degrading them, offering a safe GLP-1 alternative. People can achieve their weight-loss goals without enduring the common side effects of semaglutide and tirzepatide.”

Key Findings:

  • Trimsulin users achieved 243% greater weight loss compared to semaglutide and 139% greater weight loss compared to tirzepatide.
  • Gastrointestinal adverse effects were dramatically lower: 4.8% for Trimsulin, compared to 59.7% for semaglutide and 46% for tirzepatide.
  • Plant-Based Nutraceutical Composition: Trimsulin’s plant-based nutraceutical composition supports safe, sustainable weight loss by naturally releasing GLP-1 and GIP.

Nigel Branson, President and Co-Founder of FirstFitness Nutrition, stated, “The Trimsulin Weight Loss Program is transforming lives nationwide with an affordable, plant-based GLP-1 solution without adverse effects.”

Trimsulin is taken as a drink mix and capsules. No prescription is needed! The program includes a healthy eating and lifestyle guide based on the Mediterranean diet, offering a long-term solution for weight loss without sacrificing muscle mass.

About Trimsulin:

Trimsulin is a patent-pending, plant-based nutraceutical weight loss program that promotes lasting weight loss by naturally boosting GLP-1 and GIP levels, inhibiting DPP-4 from degrading them, and regulating blood sugar. Thermogenic agents transform stored fat into energy, accelerating weight loss while keeping you energized.

To understand the science behind Trimsulin, read the complete study: Read the study.  

To learn more and experience Trimsulin: Try Trimsulin – Click Here.

Contact Information:
For inquiries, contact the FirstFitness Nutrition Media Team at: [email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/284e36e8-de4b-4596-8b80-73e0b979bc97

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Global IIoT Adoption: Regional Analysis Reveals Unique Market Priorities and Growth Enablers Across Americas, EMEA, and APAC

United States Navy Issues Letter of Support

Digital Therapeutics Offer Hope to Rural Residents

Book Early, Earn More: Lock in Your Family’s Perfect Spring Getaway

Osisko Development Provides Infill Drilling Update on Its 13,000-m Program at Cariboo Gold Project; Intercepts Include 8.56 g/t Au Over 8.5m from 60.5m Depth, and 130.32 g/t Au Over 0.5m from 83.5m Depth

Superfortune launches AI-powered mobile app, targeting $392 billion metaphysics market beyond Web3

iStock Reveals the Visual Marketing Trends That Will Shape SMB growth in 2026

Starfish Space Completes Autonomous Rendezvous and Proximity Mission in LEO with Impulse Space

Geotab Expands Sourcewell Contract Adding Video Telematics, Asset Tracking, Data Analytics Solutions for Public Sector

Editors Picks

Global IIoT Adoption: Regional Analysis Reveals Unique Market Priorities and Growth Enablers Across Americas, EMEA, and APAC

December 15, 2025

United States Navy Issues Letter of Support

December 15, 2025

‘I’m getting lots of inquiries’ from MPs looking to join Liberals: minister

December 15, 2025

Digital Therapeutics Offer Hope to Rural Residents

December 15, 2025

Subscribe to News

Get the latest Canada news and updates directly to your inbox.

Latest News

Canada condemns Jimmy Lai’s conviction in Hong Kong, calls for his release

December 15, 2025

Book Early, Earn More: Lock in Your Family’s Perfect Spring Getaway

December 15, 2025

How Roomba invented the home robot — and lost the future

December 15, 2025
Facebook X (Twitter) Pinterest TikTok Instagram
© 2025 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version